+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

Moderate To Severe Acute Pain - Pipeline Insight, 2025 - Product Thumbnail Image

Moderate To Severe Acute Pain - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Moderate To Severe Inflammatory Acne Vulgaris- Pipeline Insight, 2025 - Product Thumbnail Image

Moderate To Severe Inflammatory Acne Vulgaris- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Moderate To Severe Plaque Psoriasis- Pipeline Insight, 2025 - Product Thumbnail Image

Moderate To Severe Plaque Psoriasis- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Mucopolysaccharidosis I - Pipeline Insight, 2025 - Product Thumbnail Image

Mucopolysaccharidosis I - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
Multiple Sclerosis - Pipeline Insight, 2025 - Product Thumbnail Image

Multiple Sclerosis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 180 Pages
  • Global
From
Multiple System Atrophy- Pipeline Insight, 2025 - Product Thumbnail Image

Multiple System Atrophy- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Muscle Spasticity - Pipeline Insight, 2025 - Product Thumbnail Image

Muscle Spasticity - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Musculoskeletal Pain - Pipeline Insight, 2025 - Product Thumbnail Image

Musculoskeletal Pain - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Epstein Barr Virus (EBV) - Pipeline Insight, 2025 - Product Thumbnail Image

Epstein Barr Virus (EBV) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Lymphangioleiomyomatosis (LAM) - Pipeline Insight, 2025 - Product Thumbnail Image

Lymphangioleiomyomatosis (LAM) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Narcotic Overdose - Pipeline Insight, 2025 - Product Thumbnail Image

Narcotic Overdose - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Papulopustular Rosacea- Pipeline Insight, 2025 - Product Thumbnail Image

Papulopustular Rosacea- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Refractory Angina- Pipeline Insight, 2025 - Product Thumbnail Image

Refractory Angina- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Adenosine Antagonists - Pipeline Insight, 2025 - Product Thumbnail Image

Adenosine Antagonists - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
From
Fibroblast Growth Factor 2 (FGFR2) - Pipeline Insight, 2025 - Product Thumbnail Image

Fibroblast Growth Factor 2 (FGFR2) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 90 Pages
  • Global
From
From
Prosthetic Joint Infections- Pipeline Insight, 2025 - Product Thumbnail Image

Prosthetic Joint Infections- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Alpha-1 Antitrypsin Deficiency- Pipeline Insight, 2025 - Product Thumbnail Image

Alpha-1 Antitrypsin Deficiency- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more